BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35241682)

  • 1. Haemagglutinin antigen selectively targeted to chicken CD83 overcomes interference from maternally derived antibodies in chickens.
    Shrestha A; Meeuws R; Sadeyen JR; Chang P; Van Hulten M; Iqbal M
    NPJ Vaccines; 2022 Mar; 7(1):33. PubMed ID: 35241682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selectively targeting haemagglutinin antigen to chicken CD83 receptor induces faster and stronger immunity against avian influenza.
    Shrestha A; Sadeyen JR; Lukosaityte D; Chang P; Smith A; Van Hulten M; Iqbal M
    NPJ Vaccines; 2021 Jul; 6(1):90. PubMed ID: 34267228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Haemagglutinin Antigen of Avian Influenza Virus to Chicken Immune Cell Receptors Dec205 and CD11c Induces Differential Immune-Potentiating Responses.
    Shrestha A; Sadeyen JR; Lukosaityte D; Chang P; Van Hulten M; Iqbal M
    Vaccines (Basel); 2021 Jul; 9(7):. PubMed ID: 34358200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of a recombinant turkey herpesvirus (H9) vaccine against H9N2 avian influenza virus in chickens with maternal-derived antibodies.
    Pan X; Liu Q; Niu S; Huang D; Yan D; Teng Q; Li X; Beerens N; Forlenza M; de Jong MCM; Li Z
    Front Microbiol; 2022; 13():1107975. PubMed ID: 36777028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Passive protection afforded by maternally-derived antibodies in chickens and the antibodies' interference with the protection elicited by avian influenza-inactivated vaccines in progeny.
    De Vriese J; Steensels M; Palya V; Gardin Y; Dorsey KM; Lambrecht B; Van Borm S; van den Berg T
    Avian Dis; 2010 Mar; 54(1 Suppl):246-52. PubMed ID: 20521640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine Efficacy of Inactivated, Chimeric Hemagglutinin H9/H5N2 Avian Influenza Virus and Its Suitability for the Marker Vaccine Strategy.
    Kim SM; Kim YI; Park SJ; Kim EH; Kwon HI; Si YJ; Lee IW; Song MS; Choi YK
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28077631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation and Comparison of the Potential Immunogenicity of Two Commercial Inactivated Bivalent Newcastle and Avian Influenza Vaccines in SPF Chicken.
    Mehrabanpour M
    Arch Razi Inst; 2019 Sep; 74(3):251-257. PubMed ID: 31592590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoadjuvant efficacy of CpG plasmids for H9N2 avian influenza inactivated vaccine in chickens with maternal antibodies.
    Pan X; Liu Q; de Jong MCM; Forlenza M; Niu S; Yan D; Teng Q; Li X; Beerens N; Li Z
    Vet Immunol Immunopathol; 2023 May; 259():110590. PubMed ID: 36990004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic immune responses to an inactivated, whole H9N2 avian influenza virus vaccine using class B CpG oligonucleotides in chickens.
    Singh SM; Alkie TN; Hodgins DC; Nagy É; Shojadoost B; Sharif S
    Vaccine; 2015 Jul; 33(32):3947-52. PubMed ID: 26092309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quick and improved immune responses to inactivated H9N2 avian influenza vaccine by purified active fraction of Albizia julibrissin saponins.
    Sun H; Fei L; Zhu B; Shi M
    BMC Vet Res; 2020 Nov; 16(1):427. PubMed ID: 33160337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. H9N2 avian influenza virus-like particle vaccine provides protective immunity and a strategy for the differentiation of infected from vaccinated animals.
    Lee DH; Park JK; Lee YN; Song JM; Kang SM; Lee JB; Park SY; Choi IS; Song CS
    Vaccine; 2011 May; 29(23):4003-7. PubMed ID: 21463681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral immunization with an attenuated
    Hajam IA; Kirthika P; Hewawaduge C; Jawalagatti V; Park S; Senevirathne A; Lee JH
    Avian Pathol; 2020 Oct; 49(5):486-495. PubMed ID: 32483989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel recombinant attenuated Newcastle disease virus expressing H9 subtype hemagglutinin protected chickens from challenge by genotype VII virulent Newcastle disease virus and H9N2 avian influenza virus.
    Xu X; Xue C; Liu X; Li J; Fei Y; Liu Z; Mu J; Bi Y; Qian J; Yin R; Ding Z
    Vet Microbiol; 2019 Jan; 228():173-180. PubMed ID: 30593364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of cross-group broadly reactive antibody response by natural H7N9 avian influenza virus infection and immunization with inactivated H7N9 vaccine in chickens.
    Hu Z; Shi L; Xu N; Wang X; Hu J; Zhao J; Liu X; Hu S; Gu M; Cao Y; Liu X
    Transbound Emerg Dis; 2020 Nov; 67(6):3041-3048. PubMed ID: 32602258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effectiveness of rHVT-H5, inactivated H5 and rHVT-H5 with inactivated H5 prime/boost vaccination regimes in commercial broiler chickens carrying MDAs against HPAI H5N1 clade 2.2.1 virus.
    Kilany WH; Hassan MK; Safwat M; Mohammed S; Selim A; VonDobschuetz S; Dauphin G; Lubroth J; Jobre Y
    Avian Pathol; 2015 Oct; 44(5):333-41. PubMed ID: 26023824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune responses of chickens inoculated with a recombinant fowlpox vaccine coexpressing HA of H9N2 avain influenza virus and chicken IL-18.
    Chen HY; Shang YH; Yao HX; Cui BA; Zhang HY; Wang ZX; Wang YD; Chao AJ; Duan TY
    Antiviral Res; 2011 Jul; 91(1):50-6. PubMed ID: 21549153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza virus-like particles harboring H9N2 HA and NA proteins induce a protective immune response in chicken.
    Li X; Ju H; Liu J; Yang D; Qi X; Yang X; Qiu Y; Zheng J; Ge F; Zhou J
    Influenza Other Respir Viruses; 2017 Nov; 11(6):518-524. PubMed ID: 28752641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Live recombinant Newcastle disease virus vectored vaccine expressing the haemagglutinin of H9N2 avian influenza virus suppresses viral replication in chickens.
    Lee J; Cho AY; Kim DH; Lee JB; Park SY; Choi IS; Lee SW; Song CS
    Avian Pathol; 2023 Apr; 52(2):100-107. PubMed ID: 36377478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of an Inactivated Avian Influenza Virus Vaccine against Circulating H9N2 in Chickens and Ducks.
    Liu Y; Zhao D; Zhang J; Huang X; Han K; Liu Q; Yang J; Zhang L; Li Y
    Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of Chickens with Maternal Immunity Against Avian Influenza Virus (AIV) by Vaccination with a Novel Recombinant Newcastle Disease Virus Vector.
    Murr M; Grund C; Breithaupt A; Mettenleiter TC; Römer-Oberdörfer A
    Avian Dis; 2020 Dec; 64(4):427-436. PubMed ID: 33347549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.